Article

Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure.

Journal of Neurosurgery (Impact Factor: 3.15). 01/1984; 59(6):945-50. DOI: 10.3171/jns.1983.59.6.0945
Source: PubMed

ABSTRACT The effect of mannitol (1.0 gm/kg) and furosemide (0.7 mg/kg), alone and in combination, on the blood-brain extracellular fluid and cerebrospinal fluid (CSF) osmotic gradient, elevated intracranial pressure (ICP), CSF and serum osmolality, and urine output was studied in 26 mongrel dogs. Mannitol and furosemide, when used together, produced a greater (62.4% versus 56.6%) and more sustained (5 hours versus 2 hours) fall in ICP than mannitol alone. This correlated with a prolongation of the reversal of the blood-brain osmotic gradient (-3.4 to + 38.5 mOsm/kg) and a rate of urine formation 15 times control values. There was a transient but not significant fall in serum Na+ with the combined treatment, but the arterial pressure did not vary from pretreatment levels. The results from this present study suggest that the distal loop diuretics in a dose of less than 1.0 mg/kg act synergistically with mannitol by causing preferential excretion of water over solute in the renal distal tubule, and thereby sustaining the osmotic gradient initially established by the mannitol infusion. It is possible, but unlikely in the doses used, that the additive effect of furosemide on reducing ICP in the presence of mannitol is due to interference with CSF formation or Na+ and H2O movement across the blood-brain barrier.

0 Bookmarks
 · 
193 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hypokalaemia from a norepinephrine infusion. We report a case of a severe hypokalaemia by intracellular shift of potassium in a sedated and ventilated head trauma patient. The kalaemia which was 3.9 mmol·L−1 at admission in the intensive care unit decreased to 1.3 mmol·L−1 during a perfusion of noradrenaline (0.3 μg·kg−1·min−1). Following the decrease of the noradrenaline dose, and administration of potassium, the kalaemia rapidly increased to 5.3 mmol·L−1 carrying a risk of arrhythmia. Therefore, kalaemia and ECG should be closely monitored when the noradrenaline doses are reduced. The causes of transcellular shift of potassium are reviewed.
    Annales Francaises D Anesthesie Et De Reanimation - ANN FR ANESTH REANIM. 01/1996; 15(2):204-206.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Children with neurological and neuromuscular diseases often present anesthetic problems in the perioperative period. The anesthetic technique can play a significant role in altering the state of the brain during neurosurgical procedures through effects on the cerebral circulation and metabolism. Pre-existing neuromuscular disease may also have specific anesthetic implications such as cardiorespiratory involvement (eg, myotonia dystrophica), the potential for drug interactions (eg, myasthenia gravis) or abnormal responses to commonly used drugs (eg, malignant hyperthermia). In this review, the perioperative anesthetic considerations in a number of common neurological and neuromuscular conditions in the pediatric patient are discussed. (J Child Neurol 1986;1:189-197)
    Journal of Child Neurology 01/1986; 1(3):189-197. · 1.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Everyone interested in neuroanaesthesia talks about intracranial pressure (ICP), but in daily clinical practice nobody measures it during craniotomy. This was the thesis that started this work more than ten years ago. A method for easy monitoring of ICP during surgery, but before opening of dura, was devised and the method was introduced in our daily clinical practice. In this chapter indications for ICP measurement, critical levels of ICP and regional differences in ICP are described. Medical approaches to ICP control are considered, including body position, hyperventilation, hypothermia and administration of barbiturate. The effect of suctioning, positive end-expiratory pressure, sedatives and analgetics are discussed as well as the use of mannitol and hypertonic saline.